Schizophrenia

Research offers promise for treating schizophrenia
January 28, 2020
Research by a University of Georgia psychologist shows that targeting one particular symptom of schizophrenia has a positive effect on other symptoms, offering significant promise for treating an aspect of schizophrenia that currently has no pharmaceutical options.
A team led by Grego...
Read More
Cognitive function in people with mental illness
January 22, 2020
A study funded by the Veterans Administration and directed by researchers at the University of Miami Miller School of Medicine has shown few differences in the profiles of genes that influence cognition between people with schizophrenia, bipolar disorder and the general population. This surprisin...
Read More
Hyperactive immune system gene causes schizophrenia-like changes in mice
January 14, 2020
Excessive activity of an immune system gene previously linked to schizophrenia reproduces neural and behavioral aspects of the disease in mice, according to a new study publishing on January 14 in the open-access journal by Ashley Comer and Alberto Cruz-Martín of Boston University and col...
Read More
Long-term medication for schizophrenia is safe, study suggests
January 10, 2020
Researchers at Karolinska Institutet in Sweden and their colleagues in Germany, the USA and Finland have studied the safety of very long-term antipsychotic therapy for schizophrenia. According to the study, which is published in the scientific journal , mortality was higher during periods when pa...
Read More
Air pollution in childhood linked to schizophrenia
January 7, 2020
Air pollution affects physical health, and research results now conclude that it also affects our psychological health. The study, which combines genetic data from iPSYCH with air pollution data from the Department of Environmental Science, shows that children who are exposed to a high level of a...
Read More
Impact of methamphetamine use depends on your genes
December 19, 2019
New research led by La Trobe University in Australia has uncovered genetic clues which could explain why some people have more severe side effects from long-term methamphetamine use than others.
The research, published in found that variations in the gene known as BDNF strongly deter...
Read More
Having a psychotic disorder may increase decline of some areas of cognition over adulthood
December 16, 2019
A new study has shown that relative to participants without a psychotic disorder, those diagnosed with a disorder were consistently impaired across all areas of cognitive (memory and thinking) ability measured. The comparison also suggested that declines in some cognitive areas might worsen with ...
Read More
New protein function could be key to treatment of drug addiction and behavioral disorders
December 5, 2019
The reward pathway of the brain causes feelings of happiness but is also involved in behavioral disorders like schizophrenia and addiction. A breakthrough study has now identified the role of a protein called Npas4 in the reward pathway, mediated by the well-known proteins MAPK and CBP, opening d...
Read More
Chronic adversity dampens dopamine production
November 13, 2019
People exposed to a lifetime of psychosocial adversity may have an impaired ability to produce the dopamine levels needed for coping with acutely stressful situations.
These findings, published today in , may help explain why long-term exposure to psychological trauma and abuse increa...
Read More
Lower IQ, family history tied to treatment-resistant schizophrenia
November 12, 2019
Those with a family history of schizophrenia and men with lower IQ are more likely to struggle with treatment resistant schizophrenia than others with the mental disorder, according to a study by researchers at Karolinska Institutet in Sweden published in the journal . The researchers say the fin...
Read More
Page 1 of 3
1 2 3